Curtis G. Oltmans's most recent trade in Fulcrum Therapeutics Inc was a trade of 225,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 24, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Fulcrum Therapeutics Inc | Curtis G. Oltmans | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2025 | 225,000 | 225,000 | - | - | Stock Option (right to buy) | |
| Avenue Therapeutics Inc | Curtis G. Oltmans | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2024 | 30,000 | 30,000 | - | - | Employee stock option (right to buy) | |
| Fulcrum Therapeutics Inc | Oltmans Curtis G. | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2024 | 150,000 | 150,000 | - | - | Stock Option (right to buy) | |
| Avenue Therapeutics Inc | Curtis G. Oltmans | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 100,000 | 100,000 | - | - | Employee stock option (right to buy) | |
| Fulcrum Therapeutics Inc | Curtis G. Oltmans | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 150,000 | 150,000 | - | - | Stock Option (right to buy) | |
| Fulcrum Therapeutics Inc | Curtis G. Oltmans | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2022 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Fulcrum Therapeutics Inc | Curtis G. Oltmans | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2022 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Fulcrum Therapeutics Inc | Curtis G. Oltmans | SVP, General Counsel | Purchase of securities on an exchange or from another person at price $ 9.01 per share. | 28 Jun 2021 | 1,088 | 1,088 (0%) | 0% | 9.0 | 9,803 | Common Stock |